generation,stage,candidate_idx,risk_aversion,herd_behavior,profit_driven,ticker,company,id,quarter,date,permno,holding_t,y_true,pred,abs_error,reward,valid,best_k,profile_strength_mode,x_risk_mean,x_herd_mean,x_profit_mean,overall_mean,raw_output,reason,answer_body
18,population,0,0.35739964260035745,0.5482994517005484,0.0942999057000943,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
18,population,1,0.36699963300036703,0.537999462000538,0.094999905000095,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
18,population,2,0.36724777727373004,0.5783902323275639,0.05436098972356357,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate market capitalization (me) and profitability (profit), with a beta below 1 indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight suggests it is a significant market component. Considering the fund's defensive profile and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate market capitalization (me) and profitability (profit), with a beta below 1 indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight suggests it is a significant market component. Considering the fund's defensive profile and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
18,population,3,0.39239960760039244,0.5682994317005684,0.039299960700039306,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and asset growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and asset growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
18,population,4,0.37699962300037704,0.5579994420005581,0.06499993500006501,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate market capitalization (me) and profitability (profit), with a beta below 1 indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight suggests it is a significant market component. Considering the fund's defensive profile and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration and turnover constraints is expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate market capitalization (me) and profitability (profit), with a beta below 1 indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight suggests it is a significant market component. Considering the fund's defensive profile and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration and turnover constraints is expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
18,population,5,0.38739961260038747,0.5282994717005284,0.08429991570008431,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and asset growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and asset growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
18,population,6,0.37714863971172535,0.5685046283838259,0.054345731510178935,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and asset growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and asset growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
18,population,7,0.37714863971172535,0.5685046283838259,0.054345731510178935,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and asset growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and asset growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
18,population,8,0.37739962260037746,0.5382994617005383,0.08429991570008431,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate market capitalization (me) and profitability (profit), with a beta below 1 indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight suggests it is a significant market component. Considering the fund's defensive profile and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration and turnover constraints is expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate market capitalization (me) and profitability (profit), with a beta below 1 indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight suggests it is a significant market component. Considering the fund's defensive profile and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration and turnover constraints is expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
18,population,9,0.3973996026003974,0.5182994817005183,0.08429991570008431,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
18,population,10,0.37739964309313706,0.5182995098441254,0.10429984706368328,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and asset growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and asset growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
18,population,11,0.356999643000357,0.5479994520005481,0.094999905000095,CVS,C V S CAREMARK CORP,732,NA,2016-04-01 00:00:00,17005,2097.25732,-0.0008386969792768295,-0.04,0.039161303020723175,-0.039161303020723175,True,1,type_mean,0.0105116667264412,0.009015847914168,2.8059538271968374,0.9418271139458155,"
<think>Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.</think>
<answer>
{""holding_log_delta"": -0.04}
</answer>","Given CVS's current fundamentals, the company has a moderate profitability (profit=0.259) and growth (Gat=0.232), with a low beta (0.795) indicating lower systematic risk than the market. The fund's current holding is substantial relative to its AUM, and the stock's S&P 500 weight is modest, suggesting it is a significant but not dominant position. Considering the fund's defensive style and low risk tolerance, a modest adjustment to align with the benchmark weight while managing concentration might be expected, likely resulting in a small negative normalized log change.","{""holding_log_delta"": -0.04}"
